# CHL1

## Overview
The CHL1 gene encodes the cell adhesion molecule L1-like protein, which is a member of the immunoglobulin superfamily and plays a pivotal role in neural development and function. This transmembrane protein is characterized by its complex structure, including multiple immunoglobulin and fibronectin type III domains, which facilitate its involvement in cell adhesion and signaling processes (Wei1998In). CHL1 is crucial for neurogenesis, axon guidance, and synaptic plasticity, contributing to the formation and maintenance of brain circuitry essential for cognitive functions such as learning and memory (Morag2011Genomewide). The gene's expression and function are implicated in various neurodevelopmental and psychiatric disorders, as well as in cancer biology, highlighting its significance in both normal physiology and disease states (Senchenko2011Differential; OnateQuiroz2023Novel).

## Structure
The CHL1 protein is a member of the L1 family of neural cell adhesion molecules and is characterized by a complex molecular structure. It features six extracellular C2-type immunoglobulin (Ig) domains followed by five fibronectin type III (FNIII) domains, a single membrane-spanning region, and a short cytoplasmic domain (Wei1998In). The cytoplasmic domain is highly conserved and contains motifs involved in intracellular cytoskeleton interactions, potentially anchoring the protein to the cytoskeleton via ankyrin (Wei1998In). 

CHL1 undergoes various post-translational modifications, including glycosylation, which is common among L1 family proteins and facilitates their function in cell adhesion and signaling (Wei1998In). The protein is also involved in forming complexes with synaptic proteins, such as Hsc70, CSP, and aSGT, which are crucial for synaptic vesicle endocytosis and neurotransmission (Andreyeva2010CHL1). 

The CHL1 gene is known to produce multiple isoforms through alternative splicing, which may result in proteins with distinct functional properties (Amann1997Characterization). These isoforms are expressed predominantly in tissues with actively dividing cells, indicating a role in cell proliferation (Amann1997Characterization).

## Function
The CHL1 gene encodes a neuronal cell adhesion molecule that is part of the immunoglobulin superfamily, playing a crucial role in neurogenesis and the maintenance of proper brain circuitry. This protein is involved in structural reorganization and signal transduction mechanisms essential for learning and memory (Morag2011Genomewide). In healthy human cells, CHL1 is implicated in the correct formation of thalamocortical circuitry, which is vital for normal brain function (Morag2011Genomewide).

CHL1 is active in the cell membrane, where it facilitates interactions between cells and the extracellular matrix, influencing neural connectivity and function. This activity is crucial for processes such as axon guidance, neuronal migration, and synaptic plasticity, which are fundamental for neural development and function (Morag2011Genomewide). The protein's role in synaptogenesis and brain circuitry is also suggested to be relevant to its function in healthy human cells (Morag2011Genomewide).

In the context of antidepressant response, CHL1 has been identified as a potential biomarker for SSRI response, with its expression levels differing significantly between cell lines with varying sensitivity to the SSRI paroxetine (Morag2011Genomewide).

## Clinical Significance
Mutations and alterations in the CHL1 gene are associated with a range of neurodevelopmental and psychiatric disorders. Deletions and duplications of the CHL1 gene have been linked to conditions such as autism spectrum disorder (ASD), intellectual disability, developmental delay, and attention deficit hyperactivity disorder (ADHD) (Li2016Novel; OnateQuiroz2023Novel). The gene's dosage is critical for normal neurological development, and both under- and overexpression can lead to cognitive impairments (Li2016Novel).

CHL1 is also implicated in schizophrenia, with studies identifying a missense polymorphism (Leu17Phe) that may affect protein function and contribute to the disorder (Sakurai2002An). CHL1-deficient mice exhibit neuroanatomical anomalies similar to those found in schizophrenia patients, suggesting a potential link between CHL1 alterations and the disease (Buhusi2017Chronic).

In cancer, CHL1 expression is differentially regulated, acting as a tumor suppressor in primary tumors and potentially promoting invasive growth in metastatic cancers (Senchenko2011Differential). The gene's expression levels have also been associated with mood disorders, including major depression, where downregulation of CHL1 is observed in patients (Yang2020Downregulation).

## Interactions
The CHL1 protein, a member of the immunoglobulin superfamily, is involved in several key interactions within the synaptic environment. It interacts with synaptic chaperones such as Hsc70, CSP, and aSGT, forming complexes like CHL1/Hsc70/aSGT and CHL1/CSP, which are crucial for the regulation of the SNARE complex involved in synaptic vesicle exocytosis (Andreyeva2010CHL1). CHL1 also binds to VAMP2 within synaptic vesicles, and this interaction is disrupted following synaptic vesicle exocytosis (Andreyeva2010CHL1).

CHL1's interaction with Hsc70 is mediated by an HPD tripeptide in its intracellular domain, which is essential for the recruitment of Hsc70 to synaptic plasma membranes and synaptic vesicles. This interaction is crucial for clathrin uncoating from clathrin-coated synaptic vesicles, a process impaired in CHL1-deficient neurons (Leshchyns’ka2006The).

CHL1 also interacts with the dopamine receptor D2 (DRD2) via its extracellular domain, specifically binding to the first extracellular loop of DRD2. This interaction suggests a role for CHL1 in modulating dopamine receptor function (Kotarska2020Cell). Additionally, CHL1 associates with the 5-HT2c receptor through its intracellular domain, indicating its involvement in serotonin receptor signaling (Kleene2015Interaction).


## References


[1. (Morag2011Genomewide) Ayelet Morag, Metsada Pasmanik-Chor, Varda Oron-Karni, Moshe Rehavi, Julia C Stingl, and David Gurwitz. Genome-wide expression profiling of human lymphoblastoid cell lines identifies chl1 as a putative ssri antidepressant response biomarker. Pharmacogenomics, 12(2):171–184, February 2011. URL: http://dx.doi.org/10.2217/pgs.10.185, doi:10.2217/pgs.10.185. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.2217/pgs.10.185)

[2. (Sakurai2002An) K Sakurai, O Migita, M Toru, and T Arinami. An association between a missense polymorphism in the close homologue of l1 (chl1, call) gene and schizophrenia. Molecular Psychiatry, 7(4):412–415, April 2002. URL: http://dx.doi.org/10.1038/sj.mp.4000973, doi:10.1038/sj.mp.4000973. This article has 88 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/sj.mp.4000973)

[3. (Buhusi2017Chronic) Mona Buhusi, Daniel Obray, Bret Guercio, Mitchell J. Bartlett, and Catalin V. Buhusi. Chronic mild stress impairs latent inhibition and induces region-specific neural activation in chl1-deficient mice, a mouse model of schizophrenia. Behavioural Brain Research, 333:1–8, August 2017. URL: http://dx.doi.org/10.1016/j.bbr.2017.06.033, doi:10.1016/j.bbr.2017.06.033. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbr.2017.06.033)

[4. (Senchenko2011Differential) Vera N. Senchenko, George S. Krasnov, Alexey A. Dmitriev, Anna V. Kudryavtseva, Ekaterina A. Anedchenko, Eleonora A. Braga, Irina V. Pronina, Tatiana T. Kondratieva, Sergey V. Ivanov, Eugene R. Zabarovsky, and Michael I. Lerman. Differential expression of chl1 gene during development of major human cancers. PLoS ONE, 6(3):e15612, March 2011. URL: http://dx.doi.org/10.1371/journal.pone.0015612, doi:10.1371/journal.pone.0015612. This article has 76 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0015612)

[5. (Kotarska2020Cell) Agnieszka Kotarska, Luciana Fernandes, Ralf Kleene, and Melitta Schachner. Cell adhesion molecule close homolog of l1 binds to the dopamine receptor d2 and inhibits the internalization of its short isoform. The FASEB Journal, 34(4):4832–4851, February 2020. URL: http://dx.doi.org/10.1096/fj.201900577RRRR, doi:10.1096/fj.201900577rrrr. This article has 9 citations.](https://doi.org/10.1096/fj.201900577RRRR)

[6. (Wei1998In) Ming-Hui Wei, Irina Karavanova, Sergey V. Ivanov, Nicolae C. Popescu, Catherine L. Keck, Svetlana Pack, Jonathan A. Eisen, and M. I. Lerman. In silico-initiated cloning and molecular characterization of a novel human member of the l1 gene family of neural cell adhesion molecules. Human Genetics, 103(3):355–364, September 1998. URL: http://dx.doi.org/10.1007/s004390050829, doi:10.1007/s004390050829. This article has 51 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s004390050829)

[7. (Yang2020Downregulation) C. R. Yang, L. Ning, F. H. Zhou, Q. Sun, H. P. Meng, Z. Han, Y. Liu, W. Huang, S. Liu, X. H. Li, B. Zheng, Dong Ming, and Xin-Fu Zhou. Downregulation of adhesion molecule chl1 in b cells but not t cells of patients with major depression and in the brain of mice with chronic stress. Neurotoxicity Research, 38(4):914–928, June 2020. URL: http://dx.doi.org/10.1007/s12640-020-00234-9, doi:10.1007/s12640-020-00234-9. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12640-020-00234-9)

[8. (Kleene2015Interaction) Ralf Kleene, Harshita Chaudhary, Nicole Karl, Jelena Katic, Agnieszka Kotarska, Kathrin Guitart, Gabriele Loers, and Melitta Schachner. Interaction between chl1 and serotonin receptor 2c regulates signal transduction and behavior in mice. Journal of Cell Science, 128(24):4642–4652, December 2015. URL: http://dx.doi.org/10.1242/jcs.176941, doi:10.1242/jcs.176941. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.176941)

[9. (Leshchyns’ka2006The) Iryna Leshchyns’ka, Vladimir Sytnyk, Melanie Richter, Aksana Andreyeva, Dmytro Puchkov, and Melitta Schachner. The adhesion molecule chl1 regulates uncoating of clathrin-coated synaptic vesicles. Neuron, 52(6):1011–1025, December 2006. URL: http://dx.doi.org/10.1016/j.neuron.2006.10.020, doi:10.1016/j.neuron.2006.10.020. This article has 76 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuron.2006.10.020)

[10. (Andreyeva2010CHL1) Aksana Andreyeva, Iryna Leshchyns’ka, Michael Knepper, Christian Betzel, Lars Redecke, Vladimir Sytnyk, and Melitta Schachner. Chl1 is a selective organizer of the presynaptic machinery chaperoning the snare complex. PLoS ONE, 5(8):e12018, August 2010. URL: http://dx.doi.org/10.1371/journal.pone.0012018, doi:10.1371/journal.pone.0012018. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0012018)

[11. (Amann1997Characterization) Joseph Amann, Vincent J. Kidd, and Jill M. Lahti. Characterization of putative human homologues of the yeast chromosome transmission fidelity gene, chl1. Journal of Biological Chemistry, 272(6):3823–3832, February 1997. URL: http://dx.doi.org/10.1074/jbc.272.6.3823, doi:10.1074/jbc.272.6.3823. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.272.6.3823)

[12. (Li2016Novel) Chunyang Li, Chunxue Liu, Bingrui Zhou, Chunchun Hu, and Xiu Xu. Novel microduplication of chl1 gene in a patient with autism spectrum disorder: a case report and a brief literature review. Molecular Cytogenetics, June 2016. URL: http://dx.doi.org/10.1186/s13039-016-0261-9, doi:10.1186/s13039-016-0261-9. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13039-016-0261-9)

[13. (OnateQuiroz2023Novel) Kenny V. Onate-Quiroz, Benjamin Udoka Nwosu, and Parissa Salemi. Novel duplication of the cell adhesion molecule l1-like gene in an individual with cognitive impairment, tall stature, and obesity: a case report. Frontiers in Neurology, April 2023. URL: http://dx.doi.org/10.3389/fneur.2023.1104649, doi:10.3389/fneur.2023.1104649. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fneur.2023.1104649)